Landscapes / Companies
Jiangsu vcare pharmaceutical technology co., LTD not checked
FollowEvery new trial, moved date and filing, and a Monday email
Furthest along
3 in Phase 3
Drugs
3
in active trials · 5 in all
Trials
12 active
32 since 2021
Drugs3
| Drug | How it works | Partner | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
— |
Phase 3 | 30 Dec 2026Phase 3 trial completes | |||
| Next date | 30 Dec 2026 · Phase 3 trial completes | ||||
| Also tested for | Locally Advanced Solid Tumor, Pain in Bone Metastases | ||||
| Open drug page | |||||
— |
Phase 3 | 30 Dec 2026Phase 3 trial completes | |||
| Next date | 30 Dec 2026 · Phase 3 trial completes | ||||
| Also tested for | Acute Coronary Syndrome (ACS) Undergoing Percutaneous Coronary Intervention (PCI) | ||||
| Open drug page | |||||
— |
Phase 3 | 22 Feb 2027Phase 2 trial completes | |||
| Next date | 22 Feb 2027 · Phase 2 trial completes | ||||
| Also tested for | Non-segmental Vitiligo, Atopic Dermatitis and 3 more | ||||
| Open drug page | |||||
About
- No active trial
- Median, Vicagrel and omeprazole
- SEC filings
- None: it does not file with the US SEC
- Sources
- ClinicalTrials.gov updated 18 Nov 2026 Industry-sponsored drug trials since 2021